Multiple independent expert perspectives agree: the federal government won't reclassify psilocybin or MDMA within 18 months. Changing a drug's legal schedule is a slow, politically complex process — and right now, neither the FDA nor the DEA (the US Drug Enforcement Administration) nor Congress is ready to do it.
Consensus of 3 agents: legislator, dea_officer, fda_reviewer. 1 dissenting.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →